Microba Life Sciences Limited (ASX: MAP) - Share Price

- Current share price for MAP : $0.044

Microba Life Sciences Limited (MAP) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It is a Company that is engaged in microbiome testing, supplements and analysis services as well as developing new pathology services, therapeutics and diagnostics based on the human gut microbiome.

MAP General Information ⁺

ASX Code	MAP
Website	http://www.microba.com
Industry/Sector	Health Care Services
Market Cap ($M)	31
MAP Share Price	$0.044
Day High	$0.045
Day Low	$0.044
Last Close	$0.044
MAP Share Price Movement	- ( No change )

Prices as at 16:40, 20 Oct 2026

⁺Security prices are delayed by at least 20 minutes and are indicative only.

Microba Life Sciences Limited (MAP) Upcoming Dividends & Yields

Distribution Type	Dividend	Franking	Ex-dividend date	Payment date	Current Price⁺	Price 7D Avg	Dividend Yield

See all dividends from Microba Life Sciences Limited (MAP) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Microba Life Sciences Limited (MAP) price-sensitive announcements

MAP - Q1 FY27 Quarterly Activities Report & Appendix 4C

Microba Life Sciences Limited’s Q1 FY27 Quarterly Activities Report and Appendix 4C for th

Microba Life Sciences Limited (MAP)
20 Oct 2026 | 9:35 AM

MAP - Microba secures $2m placement and increases cost reductions

Microba Life Sciences Limited announced it had secured firm commitments for a $2.025 milli

Microba Life Sciences Limited (MAP)
20 Oct 2026 | 9:34 AM

MAP - Appointment of Interim Chief Executive Officer

Microba Life Sciences Limited announced that Chief Executive Officer Dr Luke Reid is on me

Microba Life Sciences Limited (MAP)
25 Sep 2026 | 8:42 AM

MAP - GSS and MAP agree to Commercial Terms for Merger

Genetic Signatures and Microba announced they have agreed the principal commercial terms f

Microba Life Sciences Limited (MAP)
22 Sep 2026 | 9:25 AM

Microba Life Sciences Limited (MAP) Recent ASX Announcements

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
Microba Life Sciences Limited (MAP) ORDINARY FULLY PAID	Health Care	$32	Proposed issue of securities - MAP	20 Oct 2026 9:40AM	$0.044	$0.044	fallen by 0%
Microba Life Sciences Limited (MAP) ORDINARY FULLY PAID	Health Care	$32	Proposed issue of securities - MAP	20 Oct 2026 9:39AM	$0.044	$0.044	fallen by 0%
Microba Life Sciences Limited (MAP) ORDINARY FULLY PAID	Health Care	$32	Q1 FY27 Quarterly Activities Report & Appendix 4C	20 Oct 2026 9:35AM	$0.044	$0.044	fallen by 0%
Microba Life Sciences Limited (MAP) ORDINARY FULLY PAID	Health Care	$32	Microba secures $2m placement and increases cost reductions	20 Oct 2026 9:34AM	$0.044	$0.044	fallen by 0%
Microba Life Sciences Limited (MAP) ORDINARY FULLY PAID	Health Care	$32	Date of AGM and closing date for Director Nominations	14 Oct 2026 9:00AM	$0.050	$0.044	fallen by 12%
Microba Life Sciences Limited (MAP) ORDINARY FULLY PAID	Health Care	$32	Notification of cessation of securities - MAP	13 Oct 2026 4:47PM	$0.050	$0.044	fallen by 12%

MAP Financial Summary

Year to Jun	NPAT	EPS	EPS chg (%)	Yield (%)	Franking (%)
2026A	-$20.02	-$3.30	-23.10%	0.00%	0.0%
2025A	-$19.41	-$4.30	-10.90%	0.00%	0.0%
2024A	-$19.94	-$4.90	27.60%	0.00%	0.0%

MAP Peer Comparison

Company	Mkt Cap	EPS Growth (%)			P/E (%)			Dividend Yield (%)
Company	Mkt Cap	2024 A	2025 A	2026 A	2024 A	2025 A	2026 A	2024 A	2025 A	2026 A
Australian Clinical Labs Limited (ACL)	$535M	0.0442	-0.0111	0.0428	15.1772	15.3476	14.7179	4.53%	4.53%	4.36%
Integral Diagnostics Limited (IDX)	$785M	0.7037	0.0000	0.1877	16.0920	16.0920	13.5484	4.43%	3.57%	4.05%
Microba Life Sciences Limited (MAP)	$32M	-0.2309	0.0000	0.0000	0.0000	0.0000	0.0000	0.00%	0.00%	0.00%
Sonic Healthcare Limited (SHL)	$9,158M	0.2969	-0.1774	0.1040	13.3907	16.2787	14.7450	5.83%	5.67%	5.96%

MAP Market Comparison

	Earnings	P/E Ratio	P/B Ratio	P/E Growth
Company	0.00	0.00	1.26	0.00
Market	0.30	13.50	1.04	0.71
Sector	0.75	21.80	1.89	2.42

MAP Directors

Name	Position	Start Date
Mr Pasquale (Paddy) Rombola	Non-Executive Chairman, Non-Executive Director	23 Jun 2017
Professor Ian Hector Frazer	Non-Executive Deputy Chairman, Non-Executive Director	31 Jan 2017
Professor Gene William Tyson	Non-Executive Director	31 Jan 2017
Ms Jacqueline Fernley	Non-Executive Director	8 Sep 2022
Mr Stephane Chatonsky	Non-Executive Director	20 Nov 2025

Microba Life Sciences Limited (MAP) Changes in Directors' Interest & Trades

Date of change	Director	Buy/Sell	Security Type	Qty	Trade Price	Value
29 Jul 2026	ROMBOLA, Pasquale (Paddy)	Issued	Indirect Shares	1,250,000	$0.050	$62,500.000
29 Jul 2026	FRAZER, Ian	Issued	Indirect Shares	200,000	$0.050	$10,000.000
17 Sep 2025	BUND, Richard	Sell	Indirect Shares	690,290	$0.082	$56,672.810

See all changes in directors' interest & trades for Microba Life Sciences Limited (MAP) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

MAP Management

Name	Position
Luke Reid	Chief Executive Officer
James Heath	Chief Financial Officer,Company Secretary
Geoff Cockerill	Interim Chief Executive Officer

MAP Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Microba Life Sciences Limited (MAP). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding	Name
132,033,168 (21.68%)	Sonic Healthcare Limited
95,416,701 (13.62%)	Perennial Value Management Limited
53,123,105 (7.59%)	Mercer Investments (Australia) Limited

MAP Calendar of Events

Date	Event
30 August 2027	Report (Annual)
30 August 2027	Report (Prelim)
25 February 2027	Report (Interim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.

What our members say about us